Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIDAZOLAM vs MILNACIPRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIDAZOLAM vs MILNACIPRAN: Safety Overview

Metric MIDAZOLAM MILNACIPRAN
Total FAERS Reports 11,192 1,392
Deaths Reported 1,808 120
Death Rate 16.2% 8.6%
Hospitalizations 4,691 274
Average Patient Age 41.9 yrs 54.8 yrs
% Female Patients 49.9% 82.6%
FDA Approval Date Apr 17, 2023 Apr 22, 2016
Manufacturer SOMERSET THERAPEUTICS, LLC Cardinal Health 107, LLC
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Prescription